Jan van der Weide

Pharmacogenetics: From Bench to Byte

JJ Swen, Ingeborg Wilting, AL de Goede et al. · Clinical Pharmacology & Therapeutics · 2008 · 266 citations

Psychiatry, Medicine, Genetics +13

Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene–drug interaction of DPYD and fluoropyrimidines

Carin A.T.C. Lunenburg, Cathelijne H. van der Wouden, Marga Nijenhuis et al. · European Journal of Human Genetics · 2019 · 218 citations · Full text

The effect of genetic polymorphism of cytochrome P450 CYP2C9 on phenytoin dose requirement

Jan van der Weide, Linda S. W. Steijns, Marga J. M. van Weelden et al. · Pharmacogenetics · 2001 · 197 citations

Molecular Pharmacology, Therapeutic Drug Monitoring, Dosage Adjustment +14

The effect of smoking and cytochrome P450 CYP1A2 genetic polymorphism on clozapine clearance and dose requirement

Jan van der Weide, Linda S. W. Steijns, Marga JM van Weelden · Pharmacogenetics · 2003 · 175 citations

Molecular Pharmacology, Dosage Adjustment, Psychiatry +14

Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction between CYP2C19 and CYP2D6 and SSRIs

J. Brouwer, Marga Nijenhuis, Bianca Soree et al. · European Journal of Human Genetics · 2021 · 112 citations · Full text

Dutch Pharmacogenetics, Medicine, Pharmacogenomics +6